Arrowhead Pharmaceuticals (ARWR) Common Equity (2010 - 2026)
Arrowhead Pharmaceuticals' Common Equity came in at $466.04 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 10.3% from $519.81 million a year earlier and down 22.2% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Common Equity was $503.42 million, up 163.5% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
- Going back by fiscal year, Common Equity was $191.06 million in FY2024 (-33.5%), $287.16 million in FY2023 (-31.4%), $418.34 million in FY2022 (+2.3%) and $408.82 million in FY2021 (-11.5%).
- The fiscal Q3 2026 figure represents the lowest quarterly Common Equity since fiscal Q1 2025.
- Year-over-year, Common Equity increased in four of the last eight quarters, with growth averaging 129.3%.
- The fastest year-over-year change in Common Equity over five years came in fiscal Q1 2026 (growth of 903.5%), and the weakest in fiscal Q1 2025 (a decline of 67.7%).
- Business Quant data shows ARWR's Common Equity at $598.92 million (Q2 2026), $562.7 million (Q1 2026) and $503.42 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | 466.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 466.04 Mn |
| Mar 31, 2026 | 598.92 Mn |
| Dec 31, 2025 | 562.70 Mn |
| Sep 30, 2025 | 503.42 Mn |
| Jun 30, 2025 | 519.81 Mn |
| Mar 31, 2025 | 684.23 Mn |
| Dec 31, 2024 | 56.08 Mn |
| Sep 30, 2024 | 191.06 Mn |
| Jun 30, 2024 | 338.97 Mn |
| Mar 31, 2024 | 495.41 Mn |
| Dec 31, 2023 | 173.71 Mn |
| Sep 30, 2023 | 287.16 Mn |
| Jun 30, 2023 | 381.99 Mn |
| Mar 31, 2023 | 465.11 Mn |
| Dec 31, 2022 | 396.37 Mn |
| Sep 30, 2022 | 418.34 Mn |
| Jun 30, 2022 | 474.18 Mn |
| Mar 31, 2022 | 452.27 Mn |
| Dec 31, 2021 | 372.56 Mn |
| Sep 30, 2021 | 408.82 Mn |
API Access
Arrowhead Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();